Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers
Tafenoquine is an 8-aminoquinoline under investigation for the prevention of relapse in Plasmodium vivax malaria. This open-label, dose-escalation study assessed quantitatively the hemolytic risk with tafenoquine in female healthy volunteers heterozygous for the Mahidol(487A) glucose-6-phosphate deh...
Main Authors: | Rueangweerayut, R, Bancone, G, Harrell, E, Beelen, A, Kongpatanakul, S, Möhrle, J, Rousell, V, Mohamed, K, Qureshi, A, Narayan, S, Yubon, N, Miller, A, Nosten, F, Luzzatto, L, Duparc, S, Kleim, J, Green, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society of Tropical Medicine and Hygiene
2017
|
Similar Items
-
Asian G6PD-Mahidol reticulocytes sustain normal Plasmodium vivax development
by: Bancone, G, et al.
Published: (2017) -
Tafenoquine and G6PD: a primer for clinicians
by: Chu, CS, et al.
Published: (2019) -
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
by: Cindy S. Chu, et al.
Published: (2018-03-01) -
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
by: Chu, C, et al.
Published: (2018) -
Validation of G6PD Point-of-Care Tests among Healthy Volunteers in Yangon, Myanmar.
by: Nwe Nwe Oo, et al.
Published: (2016-01-01)